Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 525-536

  Ghadimi, B Michael ^a   Schröck, Evelin ^a   Walker, Robert L ^a   Wangsa, Danny ^a   Jauho, Annukka ^a   Meltzer, Paul S ^a   Ried, Thomas ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR;

ARTICLE; CANCER SCREENING; CHROMOSOME 2Q; CHROMOSOME ABERRATION; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; KARYOTYPING; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0344097450     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65298-4     Document Type: Article

References (46)

1. Riess LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK: SEER Cancer Statistics Review, 1973-1995. Bethesda, MD, National Cancer Institute, Cancer Statistics Branch, 1998
2. Gudjonsson B: Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995, 181:483-503
3. Conlon KC, Klimstra DS, Brennan MF: Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg 1996, 223:273-279
4. Heim S, Mitelman F: Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. New York, Wiley-Liss, 1995
5. Johansson B, Bardi G, Heim S, Mandahl N, Mertens F, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F: Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer 1992, 69:1674-1681
6. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F, Heim S: Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 1993, 67:1106-1112
7. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ: Chromomsome abnormaities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 1994, 9:93-100
8. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821
9. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi O-P: Genome screening by comparative genomic hybridization. Trends Genet 1997, 13:405-409
10. Ried T, Liyanage M, du Manoir S, Heselmeyer K, Auer G, Macville M, Schröck E: Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J Mol Med 1997, 75:801-814
11. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P: Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996, 56: 3803-3807
12. Fukushige S, Waldman F, Kimura M, Abe T, Furukawa T, Sunamura M. Kobari M, Horii A: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997, 19:161-169
13. Mahlamäki EH, Höglund M, Gorunova L, Karhu R, Dawiskiba S, Andrén-Sandberg Å, Kallioniemi O-P, Johansson B: Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997, 20:383-391
14. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T: Multicolor spectral karyotyping of human chromosomes. Science 1996, 273:494-497
15. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schröck E, Ried T: Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 1996, 14:312-315
16. Veldman T, Vignon C, Schröck E, Rowley JD, Ried T: Hidden chromosomes: abnormalities in hematological malignancies detected by multicolour spectral karyotyping. Nat Genet 1997, 15:406-410
17. Ning Y, Liang JC, Fairman J, Nagarajan L, Schröck E, Ried T: Characterization of chromosome 5q deletions by subtelomeric probes and spectral karyotyping. Cancer Genet Cytogenet 1998, 103:170-172
18. Rao P, Cigudosa JC, Ning Y, Calasanz MJ, Ida S, Tagawa S, Michalei J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RS: Multicolor spectra karyotyping (SKY) identifies new recurring breakpoints and translocations in multiple myeloma. Blood 1998, 92:1743-1748
19. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996, 93:479-484
20. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T Lichter P, Cremer T: Quantitative analysis of comparative genomic hybridization. Cytometry 1995, 19:27-41
21. Macville M, Veldman T, Padilla-Nash H, Wangsa D, O'Brien P, Schröck E, Ried T: Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements. Histochem Cell Biol 1997, 108:299-305
22. Telenius H, Pelear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjöld M, Pfragner R, Ponder BAJ: Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow sorted chromosomes. Genes Chromosomes Cancer 1992, 4:267-263
23. Garini Y, Macville M, du Manoir S, Buckwald RA, Lavi M, Katzir N, Wine D, Bar-Am I, Schröck E, Cabib D, Ried T: Spectral karyotyping. Bioimaging 1996, 4:65-72
24. Meltzer PS, Guan X-Y, Burgess A, Trent JM: Rapid generation of region specific probes by chromosome microdissection and their application. Nat Genet 1992, 1:24-28
25. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994, 8:27-32
26. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353
27. Fearon ER, Cho KR, Nigro JM, Kern SE, Simon JW, Ruppert JM, Hamilton SR, Vogelstein B: Identification of a chromosome 18q21.1. Science 1990, 247:49-56
28. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Xin-Yuan G, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast, and ovarian cancer. Science 1997, 277:965-968
29. Karger S: ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, 1995
30. Ried T, Knutzen R, Steinbeck R, Blegen H, Schröck E, Heselmeyer K, du Manoir S, Auer G: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996, 15:234-245
31. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T: Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997, 57:2331-2335
32. Heselmeyer K, Hellström A-C, Blegen H, Schröck E, Silfverswärd C. Shah K, Auer G, Ried T: Primary carcinoma of the fallopian tube: comparative genomic hybridization reveals high genetic instability and a specific, recurring pattern of chromosomal aberrations. Int J Gynecol Pathol 1998, 17:245-254
33. Höglund M, Gorunova L, Andrén-Sandberg Å, Dawiskiba S, Mitelman F, Johansson B: Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-132. Genes Chromosomes Cancer 1998, 21:8-16
34. Torchia J, Rose DW, Inostroza J, Kamel Y, Westin S, Glass CK, Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684
35. Heselmeyer K, Macville M, Schröck E, Blegen H, Hellström A-C, Shah K, Auer G, Ried T: Advanced stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome 3q. Genes Chromosomes Cancer 1997, 19:233-240
36. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S, Cremer T: Mapping of multiple DMA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994, 54:1801-1806
37. Hahn SA, Hoque ATM, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996, 56:490-494
38. Mitelman F: Catalog of chromosome aberrations in cancer New York: Wiley-Liss, 1994
39. Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M, Scarpa A: Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 1996, 56:3808-3813
40. Rowley JD: The Philadelphia chromosome translocation: a paradigm for understanding leukemia. Cancer 1990, 65:2178-2184
41. de la Chapelle A: How do isochromosomes arise? Cancer Genet Cytogenet 1982, 5:173-179
42. Horsthemke B, Gregor V, Beefier R, Passarge E: Mechanism of i(6p) formation in retinoblastoma tumor cells. Cancer Genet Cytogenet 1989, 37:95-102
43. DiGiuseppe JA, Hruban RH: Pathobiology of cancer of the pancreas. Sem Surg Oncol 1995, 11:87-96
44. Wilentz RE, Hruban RH: Pathology of cancer of the pancreas. Pancreatic Cancer 1998, 7:43-65
45. Ried T, Heselmeyer-Haddad K, Schröck E, Auer G: Genomic changes defining the genesis, progression and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 1999 (In press)
46. Ried T: Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol 1998, 152:325-327